Fluorescent Laparoscopic Central Hepatectomy for Liver Cancer Using Indocyanine Green Negative Staining

Summary

The present protocol describes fluorescent negative staining in laparoscopic central hepatectomy. This technique can make hepatectomy more accurate and precise.

Abstract

Laparoscopic hepatectomy is an important treatment method for liver cancer. In the past, the resection boundary was usually determined by intraoperative ultrasound, important vascular structures, and surgeon experience. With the development of anatomical hepatectomy, visual surgery technology has gradually been applied to this type of surgery, particularly indocyanine green (ICG)-guided anatomical hepatectomy. As ICG can be specifically ingested by hepatocytes and used for fluorescence tracing, negative staining techniques have been applied according to different tumor positions. Under ICG fluorescent guidance, the surface boundary and deep resection plane can be more accurately displayed during liver resection. Thus, the tumor-bearing liver segment can be anatomically removed, which helps to avoid damage to important vessels and reduce ischemia or congestion of the remaining liver tissue. Finally, the incidence of postoperative biliary fistula and liver dysfunction is reduced; therefore, a better prognosis is obtained after the resection of liver cancer. Centrally located liver cancer is usually defined as a tumor located at segments 4, 5, or 8 that requires resection of the middle section of the liver. These are among the most difficult hepatectomies to perform because of the large surgical wounds and multiple vessel transections. Based on the specific tumor location, we formulated the required resection ranges by designing personalized fluorescent staining strategies. By completing anatomical resection based on the portal territory, this work aims to achieve the best therapeutic effect.

Introduction

Central hepatectomy is the main surgical method used to treat liver malignancies located in segments 4, 5, and 8^1,2. Standard central hepatectomy requires the complete resection of these segments, which necessitates exposing the sagittal portion, middle hepatic vein (MHV), and right hepatic vein (RHV)³. Segments 4, 5, and 8 belong to the category of central hepatectomy².

With the advancement of precision liver surgery, anatomical hepatectomy has developed rapidly. However, the method to accurately determine the resection plane of hepatectomy is a key point and area of uncertainty. Generally, the Glisson pedicle is ligated to delimit the surface boundary according to the ischemic area⁴. For control of the deep plane, anatomical landmarks, including hepatic veins and portal branches, are often used under intraoperative ultrasound guidance during the transection⁵. Makuuchi's method shows the resection margin by injecting methylene blue into the portal vein under ultrasound guidance, exposing important hepatic veins at the liver resection plane after removing the specimen^5,6,7.

Because hepatocytes specifically absorb indocyanine green (ICG), its fluorescence clearly shows the resection boundary. Anatomical hepatectomy guided by ICG fluorescence was first reported by Aoki in 2008⁸. ICG fluorescent staining methods can be divided into positive and negative staining⁹. The negative staining technique is performed by intravenous ICG injection after clamping the segmental portal pedicle¹⁰. Then, the remnant liver displays fluorescence, but the portal territory does not. Compared with traditional methods, anatomical hepatectomy under fluorescence navigation can not only display the resection boundary on the surface of the liver, but also guide the deep resection plane. For hemihepatectomy and segmental hepatectomy, negative staining technology is recommended. To date, anatomical hepatectomy using fluorescence navigation has become a popular method for liver surgery^11,12. This article describes a negative staining technique for fluorescent laparoscopic central hepatectomy. The patients were classified preoperatively by the Child-Pugh scoring system, and accordingly, patients with class A scores were selected¹³.

Protocol

This protocol follows the guidelines of the human research ethics committee of Sun Yat-sen Memorial Hospital, Sun Yat-sen University. Written informed consent was obtained from the patients for performing this study.

1. Patient selection

1. Select patients with a malignant tumor in the middle section of the liver, including patients with hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC).
2. Ensure that these patients show no invasion of the portal or hepatic vein and no distant metastasis.

2. Patient preparation

NOTE: The patients were classified preoperatively as Child-Pugh A¹³.

1. Administer antiviral drugs, such as entecavir or tenofovir (see Table of Materials), to the patients 1 week before the operation in case they are detected with hepatitis B. In our study,tThe ICG retention rate at 15 min was <10%.
2. Perform three-dimensional reconstruction in advance¹⁴. In our study, the future liver remnant (FLR) accounted for >50% of the standard liver volume (SLV).

3. Surgical technique

1. Preoperative preparation
   1. Place the patient in a supine position, with the legs open and lying on the right side. Perform standard general anesthesia involving tracheal intubation and controlled ventilation.
      NOTE: The dosage of anesthesia varies widely from patient to patient, determined mainly based on patient characteristics, age, and other medical conditions.
   2. Ensure that the surgeon stands on the right and the assistant on the left. Place the camera in the middle of the trocar sites and the camera holder in the middle.
   3. Place the trocar (see Table of Materials) as illustrated in Figure 1.
   4. Prepare fluorescent laparoscopic equipment and B-ultrasound with a laparoscopic probe (see Table of Materials).
2. Exploration phase
   1. Perform abdominal cavity exploration from the epigastrium to the hypogastrium from left to right to reveal ascites, cirrhosis, and abdominal adhesions.
   2. Perform intraoperative ultrasound exploration of the liver. Evaluate the tumor size, location, relationship with surrounding blood vessels, and variations in the MHV and RHV.
      NOTE: The tumor size is measured by intraoperative ultrasound. The relevant data are presented in Table 1.
3. Cholecystectomy and presetting of the hepatoduodenal ligament occlusion band
   1. Anatomize Calot's triangle. Then, cut the cystic duct 5 mm from the common duct. Perform retrograde dissection of the gallbladder.
   2. Perform the hepatoduodenal ligament occlusion with a cotton string by using the Pringle maneuver¹⁵.
   3. Perform intermittent occlusion of the first porta hepatis by blocking for 15 min and opening for 5 min. Shorten the blocking time to 10 min for patients with obvious cirrhosis.
4. Resection of segments 4, 5, and 8
   1. First, separate the liver parenchyma by resecting at 1 cm on the right side of the falciform ligament. Ligate and transect several branches of the segment 4 Glisson pedicle¹⁶ using clips.
   2. Second, separate the right anterior hepatic pedicle along the Laennec's capsule⁴. Ligate or occlude the right anterior hepatic pedicle.
   3. Administer a peripheral injection of 2 mL of 1:100 diluted ICG (see Table of Materials) for negative staining, to define the boundary between the right anterior section and the right posterior section (Figure 2).
   4. Dissect the liver parenchyma along the right fluorescent border. Transect the right anterior hepatic pedicle using a linear stapler after obtaining sufficient space.
   5. Separate the MHV at the root and transect it using a linear stapler.
   6. Under fluorescence tracing, reserve the trunk of the RHV, and transect the V5d and V8d branches of the RHV¹⁷. Finish resecting the specimens.
      NOTE: ICG (25 mg ICG to 100 mL of sterile water) was diluted at a ratio of 1:100 for injection. Appropriate liver-cutting instruments, such as an ultrasonic scalpel, bipolar, cavitational ultrasonic surgical aspirator, etc., should be used, according to the surgeon's preference.
5. Resection of segments 5 and 8
   1. Separate the right anterior hepatic pedicle along the Laennec's capsule.
   2. Perform a peripheral injection of 2 mL of 1:100 diluted ICG for negative staining to define the boundaries between the left, right anterior, and right posterior sections (Figure 3).
   3. First, process the left resection plane. Dissect the liver parenchyma along the left fluorescent border, preserve the trunk of the MHV, and transect the V5v and V8v branches of the MHV.
   4. Then, transect the right anterior hepatic pedicle using a linear stapler after obtaining sufficient space.
   5. Next, dissect the liver parenchyma along the right fluorescent border. Preserve the trunk of the RHV, and transect the V5d and V8d branches of the RHV. Finish resecting the specimen.
6. Hemostasis of residual liver after hepatectomy
   1. Carefully check the residual liver and close the bleeding points one by one using bipolar electrocoagulation.
7. Specimen examination
   1. After the surgery, visually confirm that the specimen margin is negative. Additionally, examine the specimens to confirm that the tumor capsule is complete and measure the distance from the tumor to the cutting edge.
   2. Immerse the specimens in formalin and send them to the pathology department. The operation is successful if the capsule is complete or the incision margin is >1 cm.

Results

From 2020 to 2022, six patients with HCC underwent fluorescent laparoscopic central hepatectomy. Among these, four patients underwent resection of segments 4, 5, and 8, and two patients underwent resection only of segments 5 and 8 (Table 1). None of the patients were converted to open surgery. Their ages ranged from 46 to 74 years. The tumor sizes ranged from 5 to 9 cm. The median operative time was 240 min, and the median intraoperative blood loss was 450 mL. The median postoperative hospital stay was 7...

Discussion

Anatomical hepatectomy is based on portal territory, and its therapeutic effect on liver cancer is still being explored. The theoretical basis for this is that the spread of liver cancer along the portal vein is the main reason for its recurrence and metastasis¹⁸. In the 20th century, Makuuchi first proposed anatomical hepatectomy from the initial open portal vein puncture with methylene blue staining, revealing the landmark hepatic veins, which has advanced to the current preoperative analysis of...

Materials

List of materials used in this article

Name	Company	Catalog Number	Comments
BK Flex Focus 800	BK Medical	8666-RF	Intraoperative ultrasound
Entecavir	Bristol Myers Squibb	H20052237	Antiviral drugs
Hakko Sonoguide PTC Needle	Hakko-medical	PTC-B 18G/20G	Portal vein puncture
Indocyanine green	Dandong Yichuang Pharmaceutical	0902007 GH102	Fluorescent dye
PINPOINT Endoscopic Fluorescence Imaging System	Stryker	PC9000	Fluorescent laparoscope
Tenofovir	GILEAD	H20180060	Antiviral drugs
Trocar	Ethicon Endo-Surgery	B5LT/B12LT	Trocar